Fox Chase Cancer Center News

PHILADELPHIA (November 26, 2019) – Erica Golemis, PhD, professor, deputy chief science officer, leader of the Molecular Therapeutics Program, and The William Wikoff Smith Chair in Cancer Research at Fox Chase Cancer Center, has been named a 2019 Fellow of the American Association for the Advancement of Science.

PHILADELPHIA (November 25, 2019) – Phillip Abbosh, MD, PhD, a Fox Chase Cancer Center researcher, has been awarded a $658,800 grant by the U.S. Department of Defense to investigate the role of the immune system and the presence of certain bacteria in mediated responses to chemotherapy in cancers of the bladder.

PHILADELPHIA (November 25, 2019) – In their study, researchers from Fox Chase Cancer Center found that in contrast to what occurs in the development of atherosclerosis, mice that were deficient in IL-27 receptor were largely protected from angiotensin II-induced AAA.

PHILADELPHIA (November 22, 2019) – There are significant differences in breast cancer survival depending on where women live and their socioeconomic status, according to new mapping data from researchers at Fox Chase Cancer Center.

PHILADELPHIA (November 22, 2019) – A number of patients involved in clinical trials for drugs being developed to treat cancer may be malnourished and sedentary, a factor that may result in inaccurate results for the trials, according to a new study from researchers at Fox Chase Cancer Center.

PHILADELPHIA (November 21, 2019) – Physicians from the region were asked to vote on top doctors from an array of specialties, including breast, surgical, gynecologic, clinical genetics, prostate, and radiation oncology. 

PHILADELPHIA (November 21, 2019) – IF/THEN® seeks to further women in science, technology, engineering and math (STEM) by empowering current innovators and inspiring the next generation of pioneers.

PHILADELPHIA (November 20, 2019) – A researcher at Fox Chase Cancer Center, in collaboration with her colleague at Temple University, has developed an interactive Web tool that is designed to improve informed decision making for clinical trial participation among cancer patients, including those who are often underrepresented in research.